A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma

Pritesh Patel, Annie L. Oh, Matthew Koshy, Karen Sweiss, Santosh L. Saraf, John G. Quigley, Irum Khan, Nadim Mahmud, Eileen Hacker, Howard Ozer, David J. Peace, Ralph R. Weichselbaum, Bulent Aydogan, Damiano Rondelli

Research output: Contribution to journalArticle

5 Scopus citations

Fingerprint Dive into the research topics of 'A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m<sup>2</sup> and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences